Glaxo Venture's Lofty Goal in HIV: Eclipse Gilead as Top Player

Glaxo Venture's Lofty Goal in HIV: Eclipse Gilead as Top Player

GlaxoSmithKline Plc’s HIV venture wants to use less burdensome forms of treatment to unseat rival Gilead Sciences Inc. and become the top player in the $26 billion-a-year market in the mid-2020s. “If our pipeline and our competitors’ pipelines play out as we’re expecting, that’s our aim,” Deborah Waterhouse, chief executive officer of ViiV Healthcare, told […]

Two-Drug HIV Regimen May Control Virus in Treatment-Naive Patients

Two-Drug HIV Regimen May Control Virus in Treatment-Naive Patients

ViiV Healthcare reported positive results from 2 phase 3 studies which were designed to evaluate the safety and efficacy of a 2-drug regimen of dolutegravir and lamivudine in comparison with a 3-drug regimen for treatment-naïve patients with HIV. GEMINI 1 and GEMINI 2 are duplicate, phase 3 randomized, double-blind, multicenter, parallel group, non-inferiority studies. The […]

Using CRISPR to block production of HIV in infected cells

Using CRISPR to block production of HIV in infected cells

Contracting HIV is no longer the death sentence that it was in the 1980s and early 90s. The first cases of AIDS in the United States were reported in 1981, and since then the antiretroviral drugs used to treat HIV have come a long way in both safety and efficacy. HIV-positive individuals who take antiretroviral […]

Tanzania: Sigh of Relief for HIV Patients, Govt Set to Introduce New Range of ARVs

Tanzania: Sigh of Relief for HIV Patients, Govt Set to Introduce New Range of ARVs

Photo: Luca Sola/ Medicins Sans Frontiers Doctors Without Borders Selena Bishop from Ng’ombe village, undergoes her monthly consultation at Sorgin Health Centre, Nsanje. Serena is HIV positive and has come to collect her ARV refill. The clinician has recommended a malnutrition assessment (file photo). By Sylivester Domasa Dodoma — TANZANIA intends to introduce new Antiretroviral […]

Mumbai facing severe shortage of HIV drugs

Mumbai facing severe shortage of HIV drugs

The HIV treatment centres in Mumbai and other parts of the state are facing a severe shortage of second and third-line regimen drugs for the past three months. The tests and treatment for HIV/AIDS are provided for free at anti-retroviral therapy (ART) centres in major public hospitals in Mumbai and Maharashtra, with JJ Hospital in […]

Transmitted drug resistance now less likely to harm HIV treatment options, US study finds

Transmitted drug resistance now less likely to harm HIV treatment options, US study finds

The rising prevalence of transmitted antiretroviral drug resistance in the United States is unlikely to affect the success of first-line treatment in the future and is largely unconnected with recent treatment failure in people already on antiretroviral therapy, a large analysis published in Clinical Infectious Diseases shows. As a result of the rising prevalence of […]

3 Great Reasons to Buy Gilead Sciences

3 Great Reasons to Buy Gilead Sciences

You might be tempted to write off Gilead Sciences (NASDAQ:GILD). The once high-flying biotech has lost 45% of its market cap since mid-2015. After the stock climbed more than 20% earlier this year, Gilead lost all of those gains and then some. Sales for the company’s hepatitis C virus (HCV) franchise continue to drop faster […]

Health briefs 06.19.18

Health briefs 06.19.18

HIV prevention program planned The Coastal Health District HIV Prevention Program will offer free HIV testing in observance of National HIV Testing Day. Testing events will take place from 10 a.m. to 7 p.m. June 27 at Walgreens, 4575 Altama Ave., Brunswick. The first 25 people who come for testing at each Walgreens location will […]

'Game-changer' HIV prevention drug could be leading to lower condom use: studies

'Game-changer' HIV prevention drug could be leading to lower condom use: studies

Pre-exposure prophylaxis, commonly known as PrEP, is a “game-changer” when it comes to preventing HIV infections, doctors say. But some new studies are suggesting that people who take it use condoms less often — increasing their risk of contracting other sexually-transmitted infections. PrEP is a combination of two drugs, initially used to treat HIV. But […]

HIV prevention drugs could delay diagnosis if you get infected

HIV prevention drugs could delay diagnosis if you get infected

By Clare Wilson HIV tests may be giving incorrect negative results for several months in people taking pills that cut the risk of catching the virus – which could let people pass the infection on to others because they believe they are HIV-free. Pre-exposure prophylaxis (PrEP) is a combination of two drugs that reduce the […]